Results 201 to 210 of about 33,412 (306)

The oral microbiota and periodontal health in orthodontic patients

Periodontology 2000, EarlyView.
Abstract The oral microbiota develops within the first 2 years of childhood and becomes distinct from the parents by 4 years‐of‐age. The oral microbiota plays an important role in the overall health/symbiosis of the individual. Deviations from the state of symbiosis leads to dysbiosis and an increased risk of pathogenicity.
Brandon W. Peterson, Geerten‐Has Tjakkes, Anne‐Marie Renkema, David J. Manton, Yijin Ren   +4 more
wiley   +1 more source

Fusobacterium nucleatum Enhances Intestinal Adaptation of Vibrio cholerae via Interspecies Biofilm Formation. [PDF]

Microorganisms
Chen G, Chen J, Wang X, Guo D, Liu Z.
europepmc   +1 more source

Fusobacterium nucleatum-caused brain abscess – Case report

Journal of Dental Sciences, 2021
Kuan-Pin Chen, Yi-Pang Lee, Ming-Jay Hwang, Chun-Pin Chiang   +3 more
openaire   +3 more sources

Engineered surface strategies to manage dental implant‐related infections

Periodontology 2000, EarlyView.
Abstract When exposed to the oral environment, dental implants, like natural surfaces, become substrates for microbial adhesion and accumulation, often leading to implant‐related infections—one of the main causes of implant failure. These failures impose significant costs on patients, clinicians, and healthcare systems.
João Gabriel S. Souza, Bruna E. Nagay, Rodrigo Martins, Martinna Bertolini, Jamil A. Shibli, Conrado Aparicio, Magda Feres, Valentim A. R. Barão   +7 more
wiley   +1 more source

Beyond a single species: Mapping virulence traits across the redefined <i>Fusobacterium nucleatum</i> complex. [PDF]

Virulence
Wolf M, Scholz KJ, Al-Ahmad A, Steinberg T, Kruse A, Rezasoltani S, Cieplik F, Conrads G.   +7 more
europepmc   +1 more source

Emerging locally delivered antimicrobial and immunomodulatory approaches for the prevention/treatment of peri‐implant diseases

Periodontology 2000, EarlyView.
Abstract Peri‐implant diseases are dysbiosis‐mediated inflammatory disorders that occur in susceptible hosts. Antimicrobials and immunomodulatory agents therefore might be pertinent as adjunctive measures in the treatment of such disorders. The aim of this narrative review was to examine the existing evidence and assess the effectiveness of emerging ...
Alberto Monje, Ettore Amerio, Irene Mallor, Conrado Aparicio   +3 more
wiley   +1 more source

Microbial crosstalk along the oral-gut axis: organ-specific oncogenic adaptations of Porphyromonas gingivalis and Fusobacterium nucleatum. [PDF]

Neoplasia
Wu S, Ye X, Wang J, Li M, Fu Y, Wang S.
europepmc   +1 more source

Fusobacterium nucleatum Metabolically Integrates Commensals and Pathogens in Oral Biofilms

, 2022
Akito Sakanaka, Masae Kuboniwa, Shuichi Shimma, Samar A. Alghamdi, Shota Mayumi, Richard J. Lamont, Eiichiro Fukusaki, Atsuo Amano   +7 more
openalex   +1 more source

Hyaluronic acid: A novel approach in regenerative/reconstructive periodontal therapy?

Periodontology 2000, EarlyView.
Abstract Background Although hyaluronic acid (HA) has long been used for many medical applications, only in recent years has it gained greater popularity in the field of periodontics because of its biological effects during wound healing. Even today, most clinicians are not aware that more than one type of HA exists and that the extent of its ...
Andrea Pilloni, Yoshinori Shirakata, Lorenzo Marini, Darko Božić, Richard J. Miron, Roberto Rotundo, Andreas Stavropoulos, Anton Sculean   +7 more
wiley   +1 more source

The role of <i>Fusobacterium nucleatum</i> in the tumour microenvironment and carcinogenesis of oral and colonic malignancies. [PDF]

FEMS Microbes
Larionova E, Moran GP.
europepmc   +1 more source